Covid-19 vaccination: Can India deliver that shot to all?
Fri, Dec 18 2020 07:37:33 PM
New Delhi, Dec 18 (IANS): As the wealthy nations like the US and the UK begin vaccinating their public, the road ahead for India does not look very rosy as both Pfizer-BioNTech and Moderna vaccines currently making headlines are yet to reach the country owing to a host of factors including scarce supply, tricky transport and an absence of proper cold chain.
For over 130 crore Indians, two promising vaccines -- Astrazeneca and Oxford university developed and Serum Institute of India (SII)-manufactured Covishield, and Covaxin by Bharat Biotech Ltd – are still a distant dream owing to factors not in the control of the manufacturers or the government.